Last update Nov. 1, 2012
It is a Prolactin-inhibitor and Dopamine-D2-receptor selective agonist drug used on patients with hyperprolactinemia who are not responsive to Bromocriptine. There has been released reports on prolonged breastfeeding by mothers affected of prolactinoma or hyperprolactinemia, some of them were receiving treatment with Prolactin-inhibiting drugs.
We do not have alternatives for Quinagolide.
Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM